Runto Pharmaceuticals: The consistency evaluation of quality and efficacy of valacyclovir hydrochloride tablets through generic drugs.

Run Du Group Announcement: The company recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. Valacyclovir Hydrochloride Tablets passed the generic drug quality and efficacy consistency evaluation, with a specification of 0.5g and a pack size of 30 tablets/bottle. The drug approval number is National Medical License H20258207, and the drug registration standard number is YBH25122025. This drug is used to treat herpes zoster, treat herpes simplex virus infections, and prevent the recurrence of herpes simplex virus infections. This consistency evaluation will further enrich the company's product specifications, meet market demand, enhance the company's market competitiveness in the field of this drug, and have a positive impact on future business performance.